ARCHIVES

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Hyperthermia Offers Prospects For Major Treatment Advance, Investigators Says

March 11, 1977

Bristol To Support Grants For Studies On Drug Resistance

June 26, 1987

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA.

November 22, 2006